Xilio Therapeutics, Inc. (XLO)
7.82
-0.08
(-1.01%)
USD |
NASDAQ |
May 07, 16:00
7.82
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics SG&A Expense (TTM) : 29.71M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 24.60B |
| Merck & Co., Inc. | 10.88B |
| Pfizer Inc. | 10.76B |
| Verastem, Inc. | 81.14M |
| Sensei Biotherapeutics, Inc. | 9.056M |